MIAMI & JERSEY CITY, N.J., January 14, 2025--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (Noven), a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc ...
MIAMI & JERSEY CITY, N.J., January 14, 2025--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (Noven), a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., and a leader in pharmaceutical ...